JCI Insight study identifies IL1RAP as a driver of treatment resistance, with V Foundation funding…
PHARMA & CLINICAL TRIALS
Insilico Medicine (“Insilico”, HKEX: 3696), a clinical-stage biotechnology company powered by generative artificial intelligence (AI),…
Researchers at the Icahn School of Medicine at Mount Sinai have developed a new manufacturing…
New research to be presented at the European Congress on Obesity (ECO2026) in Istanbul, Turkey…
A new UK drug approval pathway, designed to speed up the availability of new medicines,…
Aerobic and resistance training combined, and high intensity interval training (HIIT), are associated with significant…
Glioblastoma remains a highly challenging malignancy with a pronounced tendency for recurrence. The hypoxic microenvironment…
Approximately 20% of patients with immune thrombocytopenia previously had minimal benefit from current therapies Results…
Investigational drug could reduce need for repeat surgeries after total knee replacement The University of…
New research suggests that certain genetic variants can decrease the ability of GLP-1 diabetes drugs…
